U.S. Pharmaceuticals & Biotech Most Popular Stocks

Monte Rosa Therapeutics

Market Cap: US$408.8m

A clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body’s natural mechanisms to selectively degrade therapeutically relevant proteins.

ADC Therapeutics

Market Cap: US$400.5m

Provides antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.

Assembly Biosciences

Market Cap: US$399.3m

A biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide.

CytomX Therapeutics

Market Cap: US$397.4m

Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.

RAPT Therapeutics

Market Cap: US$396.1m

Operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States.

4D Molecular Therapeutics

Market Cap: US$394.2m

A late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States.

Evolus

Market Cap: US$393.9m

A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.

ETHZilla

Market Cap: US$390.8m

Operates as a technology company in the decentralized finance industry.

Immuneering

Market Cap: US$383.7m

A clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients.

Aura Biosciences

Market Cap: US$383.3m

A clinical-stage biotechnology company, develops precision therapies to treat solid tumors.

Northwest Biotherapeutics

Market Cap: US$378.0m

A biotechnology company, focuses on developing personalized immune therapies for cancer.

Pacific Biosciences of California

Market Cap: US$375.5m

Designs, develops, and manufactures sequencing solution to resolve genetically complex problems.

Absci

Market Cap: US$372.3m

Operates as a data-first generative artificial intelligence (AI) drug creation company in the United States.

Benitec Biopharma

Market Cap: US$369.9m

A clinical-stage biotechnology company, focuses on the development of novel genetic medicines.

Design Therapeutics

Market Cap: US$366.7m

A clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States.

Lineage Cell Therapeutics

Market Cap: US$365.4m

A clinical-stage biotechnology company, develops novel cell therapies for neurological and ophthalmic conditions in the United States and internationally.

Mesa Laboratories

Market Cap: US$365.4m

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

Korro Bio

Market Cap: US$361.8m

A biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States.

Rocket Pharmaceuticals

Market Cap: US$358.2m

Operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States.

enGene Holdings

Market Cap: US$357.3m

Through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer.

Cullinan Therapeutics

Market Cap: US$356.2m

A clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States.

DiaMedica Therapeutics

Market Cap: US$354.1m

A clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.

Lexeo Therapeutics

Market Cap: US$353.1m

A clinical stage genetic medicine company, focuses on hereditary and acquired diseases with high unmet need in the United States.

Tvardi Therapeutics

Market Cap: US$347.2m

A clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need in the United States.

Altimmune

Market Cap: US$346.0m

A clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases.

CytoDyn

Market Cap: US$345.5m

A clinical-stage biotechnology company, develops treatments for multiple therapeutic indications.

LB Pharmaceuticals

Market Cap: US$336.6m

A clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases.

Quantum-Si

Market Cap: US$326.0m

A life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).

Replimune Group

Market Cap: US$324.7m

A clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer.

Alector

Market Cap: US$319.8m

A late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases.

Amarin

Market Cap: US$319.3m

A pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally.

Annexon

Market Cap: US$309.9m

A clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.

Galectin Therapeutics

Market Cap: US$304.3m

A clinical stage biopharmaceutical company, engages in the drug research and development to create new therapies for fibrotic, cancer, and other diseases.

Alpha Teknova

Market Cap: US$303.4m

Produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.

Editas Medicine

Market Cap: US$303.0m

A clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases.

scPharmaceuticals

Market Cap: US$302.7m

A pharmaceutical company, focuses on developing and commercializing products to optimize the delivery of infused therapies and patient care.